Therapix Biosciences - M&A Summary and Business Overview

Life ScienceCompany

Therapix Biosciences M&A Summary

Therapix Biosciences has acquired 2 companies, including 1 in the last 5 years.

Therapix Biosciences’ largest acquisition to date was in 2019, when it acquired Destiny Biosciences Global for $48M. Therapix Biosciences has acquired in 2 countries. The Company’s most targeted sectors include life science (100%).

Therapix Biosciences Business Overview

Where is Therapix Biosciences headquartered?

Therapix Biosciences is headquartered in Ness Ziona, Israel.

What sector is Therapix Biosciences in?

Therapix Biosciences is a life science company.

When was Therapix Biosciences founded?

Therapix Biosciences was founded in 2004.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 2

Therapix Biosciences Ltd.

18 Einstein Street, Science Park,
Ness Ziona,
Israel,
+972 8 939 6577
www.therapixbio.com

Therapix Biosciences Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of Senior Executives and Scientists. Its focus is creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the company is currently engaged in the following drug development programs based on repurposing an FDA-approved cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 2 - - - - - 2
vol $48M $48M
Sell (0.0/yr) # - - - - - - 0
  2

Most Recent M&A

Company Date Value Type
Destiny Biosciences Global Corp. 2019-07-23 48M USD Merger
Nisku, Alberta · www.destiny.ca
Dekel Pharmaceuticals Ltd. 2014-10-21 - Add-on Acquisition
Ramat Gan, Israel
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 2 (100%) 48M (100%) - -
Total 2 $48M - -

By Geo

State/Country Buy Value Sell Value
Canada 1 48M - -
  Alberta 1 48M - -
Israel 1 - - -
Domestic 1 (50%) - - -
Cross-border 1 (50%) 48M (100%) - -
Total 2 $48M - -

Deal Values

buy # Total
< $100M 1 $48M
TOTAL $48M
Largest Destiny Biosciences Global Corp.
$48M (2019-07-23)

 Subscribe to unlock this and 201,455
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Therapix Biosciences

Life Science Companies , Israel Companies